BofA raises ICON target to USD 185 as ICON stock gets Neutral rating

Published on 10/18/2026 at 13:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

In the second quarter of 2026, revenue reached USD 2.06 billion and net income USD 72.58 million. ICON stock reports third-quarter results October 27, 2026.

Analyst target and reporting date

BofA upgraded ICON to Neutral and raised its target to USD 185.00 on October 9, 2026.
Second-quarter 2026 revenue reached USD 2.06 billion, while net income was USD 72.58 million.
ICON is scheduled to report third-quarter 2026 results on October 27, 2026.

ICLR, IE0005711209, Illustration mit AI erstellt.

ICON Public Limited Company (ISIN IE0005711209) received a Neutral upgrade from BofA on October 9, 2026, while the bank raised its price target from USD 160.00 to USD 185.00. According to Markets Insider, the call reflected healthier contract research demand and stronger direct-fee bookings.

BofA sees demand improving

The target change came with a more constructive view of ICON's operating backdrop, but the bank still stopped at Neutral rather than a positive rating. BofA linked its view to a potential return to mid-single-digit organic growth, giving the October 9, 2026 update a specific operating rationale.

What does Q2 mean for earnings quality?

ICON's second-quarter 2026 revenue was USD 2.06 billion, up from USD 2.02 billion in the same quarter of 2025, while net income fell to USD 72.58 million from USD 182.97 million. These figures, reported by Markets Insider, put revenue resilience beside a sharp profit decline. For investors, that gap makes margin recovery and the quality of new bookings more important than revenue growth alone.

Three dated steps shape the setup

On July 30, 2026, ICON reported second-quarter revenue of USD 2.06 billion. On October 8, 2026, the company scheduled its third-quarter earnings release for October 27, 2026. On October 9, 2026, BofA upgraded ICON to Neutral and lifted its target from USD 160.00 to USD 185.00.

Upcoming reporting dates

ICON plc lists October 27, 2026 for the third-quarter results and October 28, 2026 at 8:00 a.m. EDT for the earnings conference call and webcast. The two dates give the market a near-term test of whether bookings can translate into stronger earnings.

Nasdaq listing frames the stock

ICON provides outsourced clinical development and commercialization services to pharmaceutical, biotechnology and medical device organizations. Its investor page identifies the share listing as Nasdaq and describes the company as a global provider of clinical research services. The next results will therefore put the latest demand signals and earnings quality under renewed scrutiny.

The further course of trading is shown by the continuously updated real-time quote of ICON stock.